Industry recognition highlights user-focused innovation in self-injection
Ypsomed has received another industry award for its YpsoLoop autoinjector. At the Pharmapack Awards 2026, YpsoLoop won in the category “Patient-Centric Design,” recognizing its strong focus on supporting safe, intuitive self-injection, and innovating with purpose.
Following its recent success at the CPHI Pharma Awards, this latest win further underscores strong industry recognition for YpsoLoop.
The award specifically acknowledges YpsoLoop’s patient-centered design approach. The platform supports users during self-injection through ClickGuide technology, the continuous clicking intended to reduce use errors, including early lift-off, and to increase confidence during administration. Other features include an ergonomically-shaped cap, especially supporting those with reduced dexterity.
Beyond usability, the platform also reflects Ypsomed’s broader commitment to sustainability. Designed for automated disassembly and according to ecodesign principles, YpsoLoop is also compatible with established YpsoMate fill-finish and assembly infrastructure, supporting both patient needs and pharmaceutical partner requirements.
Together, these features reflect YpsoLoop’s approach to uniting sustainability and patient convenience, an example of purposeful innovation in self-injection design. This award celebrates the dedication and technical expertise of all cross-functional contributors at Ypsomed who made this possible. Ypsomed remains focused on advancing patient-centric innovation that supports both people and the planet.
YpsoLoop is a paradigm-shifting circular solution. It provides the convenience of a pre-filled, two-step, single-use device, while enabling material recovery through a design made for automated disassembly and efficient recycling. All of this is backed by integration into existing supply chains. Learn more about this award-winning solution here.
